Mark A. Kronenfeld's most recent trade in Pacira BioSciences Inc was a trade of 11,279 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacira BioSciences Inc | Mark A. Kronenfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 11,279 | 11,279 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Mark A. Kronenfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 9,999 | 34,901 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Mark A. Kronenfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,163 | 31,065 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Mark A. Kronenfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 12,179 | 12,179 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Mark A. Kronenfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 5,230 | 24,902 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Mark A. Kronenfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,925 | 12,925 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Mark A. Kronenfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 1,775 | 19,672 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Mark A. Kronenfeld | Director | Sale of securities on an exchange or to another person at price $ 37.04 per share. | 08 Jun 2023 | 15,000 | 17,897 (0%) | 0% | 37.0 | 555,600 | Common Stock |
| Pacira BioSciences Inc | Mark A. Kronenfeld | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Mark A. Kronenfeld | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.90 per share. | 08 Jun 2023 | 15,000 | 32,897 (0%) | 0% | 29.9 | 448,500 | Common Stock |
| Pacira BioSciences Inc | Mark A. Kronenfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 8,225 | 8,225 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Mark A. Kronenfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 1,160 | 17,897 (0%) | 0% | 0 | Common Stock |